SEC Form 4 · accession 0001493152-26-039214
TAKEDA PHARMACEUTICAL CO LTD · TAK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicola Deidre Petal Greenway
Officer — Chief Human Resources Officer
Period of report
Aug 18, 2026
Accepted (ET)
Aug 19, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001395064
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Aug 18, 2026 | S | 12,980 | $18.1139 | D | 40,049 | D |
Table II — derivative securities
No Table II lines on this filing.